Migraine patients experiencing ≥ 4 monthly headache days experience reduced work productivity, high health care resource utilization and high costs
Migraines are a recurring type of headaches. According to the Centers for Disease Control and Prevention (CDC), migraine is a very common condition with ~15% Americans (18 years or older) reporting the condition in the past 3 months. Migraine is also a leading cause of disability worldwide.
A recent real-world evidence study by Dr. Buse and colleagues compared the burden of migraine among treated migraine patients who experienced ≥4 monthly headache days (MHD) with nonmigraine controls. Researchers found that:
- Migraine patients (with ≥4 MHD) experienced significantly greater absenteeism, presenteeism and overall work impairment in the previous 7 days compared to non-migraine patients
- Migraine patients (with ≥4 MHD) reported significantly higher number of HCP visits and ED visits than non-migraine patients
- Migraine patients (with ≥4 MHD) had significantly higher costs of overall health care services utilization, specifically costs of HCP visits and ED visits than non-migraine patients
“this emphasizes the need for effective management of migraine, including the appropriate use of new pharmacologic and established multidisciplinary migraine preventive treatments to lessen the effect and burden of migraine.”